Cannabidiol or better known by its initials as CBD, is one of the 113 cannabinoids found in the hemp plant, specifically in the female flowers of the hemp.
Cannabidiol is not psychoactive unlike THC or also known as tetrahydrocannabinol and has a very wide scope for medical applications such as epilepsy and epileptic encephalopathies such as West syndrome, multiple sclerosis, anxiety disorders, schizophrenia, nausea, etc.
It causes a sedative effect in most cases and inhibits the transmission of nerve signals associated with pain. Many studies reveal that CBD reduces the growth of cancer cells, of human breast cancer in vitro, and reduces their invasiveness. Therefore, CBD represents the first non-toxic exogenous agent that can lead to an inhibition of tumor aggressiveness.
Cannabidiol has also been shown to especially inhibit the growth of cancer cells without greatly affecting non-cancer cells. In medicine, it has been used to relieve anxiety, nausea, inflammation, seizures, etc.
According to recent studies, cannabidiol has also been shown to be effective in treating the effects of Parkinson’s. Since this is an incurable disease, these studies focused on improving the health of patients, obtaining satisfactory results in terms of reducing tremors and, thanks to its anti-inflammatory effect, in reducing certain neuronal inflammation in the area of the black substance, characteristic is characteristic of the disease.